Adipogenesis and aging: does aging make fat go MAD?
- PMID: 12175476
- DOI: 10.1016/s0531-5565(02)00014-1
Adipogenesis and aging: does aging make fat go MAD?
Abstract
In advanced old age, fat depot size declines while lipid is redistributed to muscle, bone marrow, and other tissues. Decreased fat depot size is related to reduced fat cell size and function and impaired differentiation of preadipocytes into fat cells. Reduced differentiation-dependent gene expression results from decreased abundance of the adipogenic transcription factors, CCAAT/enhancer binding alpha (C/EBPalpha) and peroxisome proliferator activated receptor gamma (PPARgamma). Increased expression of anti-adipogenic C/EBP family members contributes, perhaps due to cellular stress response pathway activation with aging. Hence, dysfunctional adipocyte-like cells appear in adipose tissue that are smaller and less insulin responsive than fully differentiated fat cells. Adipogenesis can be restored by overexpressing adipogenic transcription factors in preadipocytes from old animals. Redistribution of lipid to extra-adipose sites with aging could result from loss of lipid storage capacity in fat depots, altered fatty acid handling resulting in lipid accumulation, dysdifferentiation of mesenchymal precursors, such as muscle satellite cells and osteoblast precursors, into a partial adipocyte phenotype, or a combination of these mechanisms. Thus, accumulation of mesenchymal adipocyte-like default (MAD) cells in fat depots, muscle, bone marrow, and elsewhere is a potentially reversible process that could contribute to maldistribution of fat in old age.
Similar articles
-
Altered expression of C/EBP family members results in decreased adipogenesis with aging.Am J Physiol Regul Integr Comp Physiol. 2001 Jun;280(6):R1772-80. doi: 10.1152/ajpregu.2001.280.6.R1772. Am J Physiol Regul Integr Comp Physiol. 2001. PMID: 11353682
-
Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis.Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1810-9. doi: 10.1152/ajpendo.00295.2007. Epub 2007 Oct 2. Am J Physiol Endocrinol Metab. 2007. PMID: 17911345
-
Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.Cancer Res. 2001 Mar 1;61(5):2250-5. Cancer Res. 2001. PMID: 11280794
-
Hormonal signaling and transcriptional control of adipocyte differentiation.J Nutr. 2000 Dec;130(12):3116S-3121S. doi: 10.1093/jn/130.12.3116S. J Nutr. 2000. PMID: 11110883 Review.
-
Forming functional fat: a growing understanding of adipocyte differentiation.Nat Rev Mol Cell Biol. 2011 Sep 28;12(11):722-34. doi: 10.1038/nrm3198. Nat Rev Mol Cell Biol. 2011. PMID: 21952300 Free PMC article. Review.
Cited by
-
FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca(2+)/CREB pathway.Aging Cell. 2015 Jun;14(3):409-20. doi: 10.1111/acel.12331. Epub 2015 Mar 6. Aging Cell. 2015. PMID: 25754247 Free PMC article.
-
Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling.J Biol Chem. 2005 Jun 17;280(24):22688-96. doi: 10.1074/jbc.M412953200. Epub 2005 Apr 20. J Biol Chem. 2005. PMID: 15845540 Free PMC article.
-
Rosiglitazone modifies the adipogenic potential of human muscle satellite cells.Diabetologia. 2006 Aug;49(8):1962-73. doi: 10.1007/s00125-006-0304-6. Epub 2006 Jun 24. Diabetologia. 2006. PMID: 16799780
-
Aging in adipocytes: potential impact of inherent, depot-specific mechanisms.Exp Gerontol. 2007 Jun;42(6):463-71. doi: 10.1016/j.exger.2007.03.003. Epub 2007 Mar 25. Exp Gerontol. 2007. PMID: 17507194 Free PMC article. Review.
-
Adipose tissue aging: mechanisms and therapeutic implications.Cell Death Dis. 2022 Apr 4;13(4):300. doi: 10.1038/s41419-022-04752-6. Cell Death Dis. 2022. PMID: 35379822 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical